wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38630472-B3301D0C-E749-489B-BCB9-9774193A8FA5
Q38630472-B3301D0C-E749-489B-BCB9-9774193A8FA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38630472-B3301D0C-E749-489B-BCB9-9774193A8FA5
Advances in targeted therapy for the treatment of patients with relapsed/refractory multiple myeloma.
P2860
Q38630472-B3301D0C-E749-489B-BCB9-9774193A8FA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38630472-B3301D0C-E749-489B-BCB9-9774193A8FA5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
514e09bcf9836d3f35299cec35375b9cb7902d30
P2860
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.